Correlation Between Franklin Biotechnology and Transamerica Inflation

Can any of the company-specific risk be diversified away by investing in both Franklin Biotechnology and Transamerica Inflation at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Biotechnology and Transamerica Inflation into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Biotechnology Discovery and Transamerica Inflation Opportunities, you can compare the effects of market volatilities on Franklin Biotechnology and Transamerica Inflation and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Biotechnology with a short position of Transamerica Inflation. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Biotechnology and Transamerica Inflation.

Diversification Opportunities for Franklin Biotechnology and Transamerica Inflation

0.81

Correlation Coefficient

Franklin Biotechnology  Transamerica Inflation

Very poor diversification

The 3 months correlation between Franklin and Transamerica is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and Transamerica Inflation Opportu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transamerica Inflation and Franklin Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Biotechnology Discovery are associated (or correlated) with Transamerica Inflation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transamerica Inflation has no effect on the direction of Franklin Biotechnology i.e., Franklin Biotechnology and Transamerica Inflation go up and down completely randomly.

Pair Corralation between Franklin Biotechnology and Transamerica Inflation

Assuming the 90 days horizon Franklin Biotechnology Discovery is expected to generate 3.79 times more return on investment than Transamerica Inflation. However, Franklin Biotechnology is 3.79 times more volatile than Transamerica Inflation Opportunities. It trades about 0.02 of its potential returns per unit of risk. Transamerica Inflation Opportunities is currently generating about 0.02 per unit of risk. If you would invest  11,740  in Franklin Biotechnology Discovery on October 24, 2024 and sell it today you would earn a total of  1,046  from holding Franklin Biotechnology Discovery or generate 8.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	99.8%
Values	Daily Returns

Franklin Biotechnology Discove  vs.  Transamerica Inflation Opportu

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Transamerica Inflation

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Transamerica Inflation Opportunities has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Transamerica Inflation is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Franklin Biotechnology and Transamerica Inflation

The main advantage of trading using opposite Franklin Biotechnology and Transamerica Inflation positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Biotechnology position performs unexpectedly, Transamerica Inflation can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transamerica Inflation will offset losses from the drop in Transamerica Inflation's long position.

The idea behind Franklin Biotechnology Discovery and Transamerica Inflation Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.